The Keio University-backed digital medicine developer has secured $19.3m from a consortium including several Japanese corporations.

RA Capital Management and Rock Springs Capital have co-led a series B round for the gene editing technology developer spun out of Stanford six months ago.

The Future Value Fund I will invest in pre-seed companies, including spinouts from Rev1's long-time partner Ohio State University.

The regenerative therapy developer is based on research at University of Torino and has raised capital from returning backer V-Bio Ventures.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Cybrexa has secured $25m to progress a cancer treatment based on research at Yale University and University of Rhode Island.

Cuberg has developed more efficient battery cells that are used by clients such as Boeing, whose corporate venturing arm is a shareholder in the Stanford spinout.

The commercialisation firm will pay its maiden dividend after achieving net portfolio gains of 22% and a 140% increase in cash realisations.

Ohio State University’s insurtech developer Mobikit has been bought by Azuga for an undisclosed amount.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.